国家知识产权局：瑞德西韦药物已获3项专利授权

State Intellectual Property Office: radcivir has obtained 3 patent authorizations

国家知识产权局副局长何志敏25日在国务院联防联控机制新闻发布会上说，吉利德公司在中国申请了有关瑞德西韦药物的8项专利，其中3项已经授权，5项正在审查过程中；

He Zhimin, deputy director of the State Intellectual Property Office, said at the press conference of the joint defense and joint control mechanism of the State Council on the 25th that Gilead has applied for 8 patents related to ridcivir in China, of which 3 have been authorized and 5 are under review;

保护范围涵盖化合物、制剂和相关制造方法、用途等。瑞德西韦正在武汉多家医院进行临床试验，4月27日公布试验结果。

The scope of protection covers compounds, preparations and related manufacturing methods, applications, etc. Radcivir is conducting clinical trials in several hospitals in Wuhan. The results of the trials were released on April 27.

贯标认证 知识产权管理体系 贯标认证公司 贯标认证补贴 企业知识产权管理规范 知识产权 企业知识产权管理体系 知识产权认证 知识产权管理手册 知识产权管理

Implementation of standards and certification intellectual property management system implementation of standards and certification company implementation of standards and certification subsidy enterprise intellectual property management standard intellectual property management system intellectual property certification intellectual property management manual intellectual property management manual